•
Jun 30, 2024

Nkgen Biotech Q2 2024 Earnings Report

Total Revenue
$0
0
EPS
-$0.67
Previous year: -$0.59
+13.6%
Gross Profit
-$326K
0
Cash and Equivalents
$329K
Previous year: $41.5K
+693.6%
Free Cash Flow
-$6M
Previous year: -$552K
+986.7%
Total Assets
$26.4M
Previous year: $63.6M
-58.6%

Nkgen Biotech

Nkgen Biotech